tiprankstipranks
Kiora Pharmaceuticals (KPRX)
NASDAQ:KPRX
US Market

Kiora Pharmaceuticals (KPRX) Income Statement

Compare
448 Followers

Kiora Pharmaceuticals Income Statement

Last quarter (Q3 2024), Kiora Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Kiora Pharmaceuticals's net income was $-3.41M. See Kiora Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 12.06K$ 2.69M
Gross Profit
$ -4.03M$ -134.03K$ -227.27K$ -188.16K$ 2.68M
Operating Expenses
$ 8.56M$ 11.73M$ 10.67M$ 8.22M$ 9.80M
Depreciation and Amortization
$ 62.42K$ 134.03K$ 227.27K$ 200.22K$ 213.93K
EBITDA
$ -12.35M$ -13.55M$ -13.73M$ -6.65M$ -6.79M
Operating Income
$ -12.59M$ -12.31M$ -16.94M$ -8.19M$ -7.00M
Other Income/Expenses
$ 163.32K$ -1.39M$ 272.48K$ 19.15K$ 107.74K
Pretax Income
$ -12.42M$ -13.70M$ -16.70M$ -8.08M$ -7.00M
Net Income
$ -12.51M$ -13.58M$ -16.39M$ -8.09M$ -7.10M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -24.25$ -18.55$ -68.00$ -70.50$ -89.24
Diluted EPS
$ -24.25$ -18.55$ -68.00$ -70.50$ -89.24
Weighted Average Shares Outstanding
538.01K 732.30K 241.10K 114.79K 79.53K
Weighted Average Shares Outstanding (Diluted)
538.01K 732.30K 241.10K 114.79K 79.53K
Currency in USD

Kiora Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis